Yasuyuki Matsumoto1, Tongzhong Ju1

  • 1Office of Biotechnology Products, Center for Drug Evaluation and Research, The U.S. Food and Drug Administration, Silver Spring, MD 20993, USA.

Cancers
|July 29, 2023
PubMed
概括

癌细胞中改变的糖化形成独特的瘤相关碳水化合物抗原 (TACA). 这些TACA是癌症免疫疗法和诊断的有希望的目标,其中一些已经在临床使用中.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K